Navigation Links
FDA Approves the SynCardia Total Artificial Heart With SynHall Valves
Date:8/5/2014

ia">@SynCardia
  • Connect with SynCardia onLinkedIn
  • Share and Discover on Google+
  • About the SynCardia temporary Total Artificial Heart

    SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.

    Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

    More than 1,300 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.

    SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by 175 patients, accounting for over 100 years of support.

    Photo - http://photos.prnewswire.com/prnh/20140804/133128


    '/>"/>
    SOURCE SynCardia Systems, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2

    Related biology technology :

    1. USDA/GIPSA Approves Charm Sciences’ ROSA® FAST Aflatoxin Quantitative Test
    2. Kansas Bioscience Authority Approves $700,000 in Investments
    3. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
    4. ABET Approves Criteria for Optics and Photonics Engineering Undergraduate Degrees in United States
    5. 2012 American Business Awards?Honors SynCardia with Two Gold Stevie® Awards
    6. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
    7. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
    8. Nebraska Medical Center Implants States First SynCardia Total Artificial Heart
    9. SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre
    10. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
    11. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... CA (PRWEB) December 17, 2014 ... today that it has entered into a technology ... Company (ADM) to apply DNA2.0’s proprietary protein engineering ... engineering process. , “We are extremely excited that ... engineering platform. This proprietary bioengineering technology has ...
    (Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
    (Date:12/15/2014)... PETACH TIKVAH, Israel , Dec. 15, ... BCLI ), a leading developer of adult stem cell ... Brainstorm Cell Therapeutics Ltd. was awarded a grant of ... Office of the Chief Scientist (OCS).  This is the ... grant support from the Office of the Chief Scientist, ...
    (Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma ... TransCon technology to address significant unmet medical needs, ... ongoing Phase 2 pediatric study to evaluate once-weekly ... deficiency, or GHD.  This interim analysis consists of ... total enrollment in the study, completing all six ...
    Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
    ... Calif., Oct. 10 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... on Monday, October 13, to provide an update on ... stroke.,Hosting the call will be Paul E. Freiman, president ... officer., -- Date: Monday, October 13, ...
    ... effects of, recombinant lactoferrin (tradename: Lacromin) in mammalian ... leading to a significant boost ... A recently published study,in the scientific journal In Vitro ... see, http://www.Lacromin.com ) is a strong growth factor for ...
    ... CORPUS CHRISTI, Texas, Oct. 10 CSMG,Technologies, ... management,company, announced the company has received approval ... on a key divisional application for "Bonding ... Electric Current,Therethrough" for CSMG Technologies subsidiary Live ...
    Cached Biology Technology:Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3
    (Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, a ... Internet of Things (IoT), today announced the appointment of ... operating officer. Previously a strategic advisor to the firm, ... operations. Mr. Traynor is based out of the C-Labs ... reports to Chris Muench , Chief Executive Officer. ...
    (Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
    (Date:11/18/2014)... 2014 The Parenteral Drug Association (PDA) today confirmed ... speak and at least seven more will participate in the ... Shoreham Hotel in Washington D.C. , Dec. ... significant support from the regulatory agencies in the ... in our effort to help advance the use of metrics ...
    Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
    ... is pleased to name the latest recipients of its ... of Hospital for Special Surgery (HSS), Dipyaman Ganguly, PhD ... of the Feinstein Institute at North Shore-Long Island Jewish ... S.L.E. Lupus Foundation,s lifetime investment in New York City-based ...
    ... premature aging of immune cells, which may make people more ... new UCSF-led study. The findings indicate that accelerated ... is dependent upon how long someone is depressed, particularly if ... March 2011 by the journal PLoS One and ...
    ... -- Companies looking to engineer an eco-friendly diesel fuel have ... University researchers, making petroleum diesel completely green would not only ... green. "Fossil fuels are limited, and since we can,t ... are looking for alternative fuel sources like algae," said Peter ...
    Cached Biology News:S.L.E. Lupus Foundation announces new grants to further NYC scientists' leadership in lupus research 2S.L.E. Lupus Foundation announces new grants to further NYC scientists' leadership in lupus research 3Study finds link between chronic depression and accelerated immune cell aging 2Study finds link between chronic depression and accelerated immune cell aging 3Economics, physics are roadblocks for mass-scale algae biodiesel production, study finds 2Economics, physics are roadblocks for mass-scale algae biodiesel production, study finds 3Economics, physics are roadblocks for mass-scale algae biodiesel production, study finds 4